Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens

<i>Background and Objectives</i>: We investigated and compared the efficacy of three and five monthly loading regimens of an intravitreal aflibercept injection (IVA) in patients with diabetic macular edema (DME). <i>Materials and Methods</i>: This was a retrospective study th...

Full description

Bibliographic Details
Main Authors: Yoo-Ri Chung, Kyung Ho Lee, Kihwang Lee
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/59/3/558
_version_ 1827748816360570880
author Yoo-Ri Chung
Kyung Ho Lee
Kihwang Lee
author_facet Yoo-Ri Chung
Kyung Ho Lee
Kihwang Lee
author_sort Yoo-Ri Chung
collection DOAJ
description <i>Background and Objectives</i>: We investigated and compared the efficacy of three and five monthly loading regimens of an intravitreal aflibercept injection (IVA) in patients with diabetic macular edema (DME). <i>Materials and Methods</i>: This was a retrospective study that included patients diagnosed with DME and treated with an either three or five monthly aflibercept loading regimen from July 2018 to March 2022. Information on clinical characteristics and changes in the central retinal thickness (CRT) were obtained from medical records. <i>Results</i>: In total, 44 eyes of 44 patients with DME treated with IVA were included in this study, with 30 eyes treated with 3-monthly loadings (three-loading group) and 14 eyes with 5-monthly loadings (five-loading group). The mean CRT significantly decreased from the baseline one month after loading in both the three-loading and five-loading groups (<i>p</i> < 0.001). Four cases were refractory to treatment in the three-loading group, while there were no cases of refractory DME in the five-loading group. The stability rate was significantly higher in the five-loading group at three months after loading (<i>p</i> = 0.033). <i>Conclusions</i>: Five-monthly loading regimens of IVA might be favorable for DME considering the rate of refractory cases, stable duration, and the importance of early responsiveness to IVA in DME.
first_indexed 2024-03-11T06:12:14Z
format Article
id doaj.art-490391a769d74a4e9370dfc0103af240
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-11T06:12:14Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-490391a769d74a4e9370dfc0103af2402023-11-17T12:32:21ZengMDPI AGMedicina1010-660X1648-91442023-03-0159355810.3390/medicina59030558Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading RegimensYoo-Ri Chung0Kyung Ho Lee1Kihwang Lee2Department of Ophthalmology, Ajou University School of Medicine, Suwon 16499, Republic of KoreaLove Eye Clinic, Hwaseong 18309, Republic of KoreaDepartment of Ophthalmology, Ajou University School of Medicine, Suwon 16499, Republic of Korea<i>Background and Objectives</i>: We investigated and compared the efficacy of three and five monthly loading regimens of an intravitreal aflibercept injection (IVA) in patients with diabetic macular edema (DME). <i>Materials and Methods</i>: This was a retrospective study that included patients diagnosed with DME and treated with an either three or five monthly aflibercept loading regimen from July 2018 to March 2022. Information on clinical characteristics and changes in the central retinal thickness (CRT) were obtained from medical records. <i>Results</i>: In total, 44 eyes of 44 patients with DME treated with IVA were included in this study, with 30 eyes treated with 3-monthly loadings (three-loading group) and 14 eyes with 5-monthly loadings (five-loading group). The mean CRT significantly decreased from the baseline one month after loading in both the three-loading and five-loading groups (<i>p</i> < 0.001). Four cases were refractory to treatment in the three-loading group, while there were no cases of refractory DME in the five-loading group. The stability rate was significantly higher in the five-loading group at three months after loading (<i>p</i> = 0.033). <i>Conclusions</i>: Five-monthly loading regimens of IVA might be favorable for DME considering the rate of refractory cases, stable duration, and the importance of early responsiveness to IVA in DME.https://www.mdpi.com/1648-9144/59/3/558afliberceptdiabetic retinopathymacular edemaintravitreal injection
spellingShingle Yoo-Ri Chung
Kyung Ho Lee
Kihwang Lee
Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
Medicina
aflibercept
diabetic retinopathy
macular edema
intravitreal injection
title Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
title_full Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
title_fullStr Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
title_full_unstemmed Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
title_short Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
title_sort clinical application of intravitreal aflibercept injection for diabetic macular edema comparing two loading regimens
topic aflibercept
diabetic retinopathy
macular edema
intravitreal injection
url https://www.mdpi.com/1648-9144/59/3/558
work_keys_str_mv AT yoorichung clinicalapplicationofintravitrealafliberceptinjectionfordiabeticmacularedemacomparingtwoloadingregimens
AT kyungholee clinicalapplicationofintravitrealafliberceptinjectionfordiabeticmacularedemacomparingtwoloadingregimens
AT kihwanglee clinicalapplicationofintravitrealafliberceptinjectionfordiabeticmacularedemacomparingtwoloadingregimens